Search Media Items

Information to help people think about whether taking part in a cancer clinical trial is right for them. Covers benefits and risks of taking part, as well as eligibility criteria.

Information about placebos and their role in cancer clinical trials.

Provides trainees with a balanced combination comprehensive cancer biology, engineering, and entrepreneurship didactic training, including cancer researcher, clinical/translational cancer faculty, and practical skills in small business environments.

Resumen de información revisada por expertos sobre el uso del sulfato de hidracina como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.

Information about randomization and bias in cancer clinical trials.

Funding opportunities that address the goals of the Blue Ribbon Panel are available. Learn more about these FOAs and pre-application webinars.

Will offer nanotherapeutic formulations and novel approaches targeting multiple components of the tumor and its microenvironment, specifically for high-grade serous ovarian cancers.

Information about the phases of cancer clinical trials. If a new treatment is successful in one phase, it will proceed to further testing in the next phase.

Information about the several types of cancer clinical trials, including treatment trials, prevention trials, screening trials, supportive and palliative care trials. Each type of trial is designed to answer different research questions.

Information about the basics of cancer clinical trials.